OptumRx Strikes Deal With Point32Health for PBM Solutions
OptumRx has reached an agreement with the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, Point32Health. Pharmacy [...]
OptumRx’s Calabrese: Top 3 Drugs in Pipeline
OptumRx Senior Vice President and Chief Pharmacy Officer David Calabrese in a recent interview with Managed Healthcare Executive discusses the [...]
OptumRx: Rising Orphan Drug Competition Could Lead to Lower Prices
Increased competition in the orphan drug market could ultimately help pull down prices, OptumRx suggests in a new report. According [...]
OptumRx: Payers Should Monitor Three Key Drugs
OptumRx in its latest drug pipeline update recommends payers to keep an eye on risdiplam, viltolarsen and trodelvy, FierceHealthcare reports. [...]
Advertisement
